Olainfarm: Recording of the Third Quarter 2017 Investor Conference Webinar

On January 11 JSC Olainfarm organized its Investor Conference Online Webinar.
During the webinar the member of the management board of JSC Olainfarm Salvis
Lapinš analyzed the financial results of third quarter 2017 and informed about
the other recent activities within the company. 

Olaine, 2018-01-15 21:06 CET (GLOBE NEWSWIRE) --
During the webinar, Salvis Lapinš received a question on the amount of
receivables overdue for 90 and more days that are unprovided for. The amount
totaled 1.4 million euros as of October 1st, 2017. 

The recorded JSC Olainfarm webinar is available online:
http://ej.uz/OLF_Q3_2017, and the presentation, demonstrated during the
webinar, is available in the previously published company's announcement:
http://ej.uz/OLF_Q32017_EN. 

Olainfarm thanks all participants, who joined the webinar, and encourages
everybody to follow company's announcements to get information on the next
webinar! 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45
years of experience in production of medication and chemical and pharmaceutical
products. A basic principle of company's operations is to produce reliable and
effective top quality products for Latvia and the rest of the world. Products
made by the Group are being exported to more than 50 countries of the world,
including the Baltics, Russia, other CIS, Europe, Asia, North America and
Australia. 

         Information prepared by:
         
         Salvis Lapins
         JSC Olainfarm
         Member of the Management Board
         Rupnicu iela 5, Olaine, Latvia, LV 2114
         Phone: [phone]
         Fax: [phone]
         E-mail: [e-mail]